Qurate Retail Inc Series A vs 10X Genomics Inc — how do they compare? Qurate Retail Inc Series A trades at $0.04 (market cap $653.75K), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: 10X Genomics Inc is far larger — about 8382.4× Qurate Retail Inc Series A's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Qurate Retail Inc Series A nearer its low. Which is the better fit depends on your goals.
| QVCAQ | TXG | |
|---|---|---|
Market Cap | $653.75K | $5.48B |
Sector | Consumer Cyclical | Health |
52-Week High | $15.03 | $47.20 |
52-Week Low | $0.05 | $11.34 |
Enterprise Value | $4.73B | $5.02B |
Trailing returns across standard periods
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →